Walter Ling, MD

Dr. Ling is Professor Emeritus of Psychiatry and the Founding Director of the Integrated Substance Abuse Programs (ISAP) at UCLA, one of the foremost substance abuse research groups in the US. He received his MD from Chulalonghorn University Medical School in Thailand and completed his residency at Washington University in St. Louis. He is board-certified in neurology and psychiatry, is active in research and clinical work, and has been listed in “Best Doctors in America,” “Best Doctors in the West” and “Best Doctors in Los Angeles.” Dr. Ling’s research in opiate pharmacotherapy provided pivotal information for the approval of buprenorphine and naltrexone. His current research focus includes abuse and dependence on methamphetamine, cocaine, heroin and prescription opiates; opiate induced hyperalgesia, treatment of pain in opiate-maintained patients, including those treated with buprenorphine and the role of buprenorphine in the management of pain in these patients.